Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

New tools for experimental diabetes research: Cellular reprogramming and genome editing.

Upsala journal of medical sciences - 1 May 2016

Otonkoski Timo

Abstract excerpt

Isolated human islets are a rare and precious material for diabetes research. However, their availability is limited, and it is impossible to obtain them from patients with specific genotypes. Human pluripotent stem cells provide an alternative. Induced pluripotent stem cells can be generated from any individual's somatic cells and differentiated into pancreatic cells. Currently, this approach is limited by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Research
Share to Cellular Reprogramming
Share to CRISPR-Cas Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Experimental

Share to Gene Editing

Share to Islets of Langerhans

Share to Pancreas

Share to Pluripotent Stem Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 27007444
DOI: 10.3109/03009734.2016.1149529
PMCID: PMC4900076

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

New tools for experimental diabetes research: Cellular reprogramming and genome editing.PMID 27007444Read ↗

Applications of iPSC-derived beta cells from patients with diabetesSemantic proximity Read ↗

Genome editing of human pancreatic beta cell models: problems, possibilities and outlookSemantic proximity Read ↗

Recent Progress of Research Regarding the Applications of Stem Cells for Treating Diabetes MellitusSemantic proximity Read ↗

Stem cell approaches for diabetes: towards beta cell replacementSemantic proximity Read ↗

Human Pluripotent Stem Cells to Model Islet Defects in Diabetes.Semantic proximity Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biologySemantic proximity Read ↗

Pancreatic Beta Cell Differentiation From Human Pluripotent Stem CellsSemantic proximity Read ↗

Potential of pluripotent stem cells for diabetes therapy.Semantic proximity Read ↗

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?Semantic proximity Read ↗

Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”Semantic proximity Read ↗

Applications of Genome-Editing Technologies for Type 1 DiabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.